Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

The phase 2 BESTOW trial evaluated the safety and efficacy of tegoprubart vs tacrolimus in the prevention of rejection in patients undergoing kidney transplantation.

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

Black box warning is the most serious from the U.S. Food and Drug Administration, and critics say there is no justification so far.

ADT speeds coronary atherosclerosis, with greater effects with use of the GnRH-agonist leuprolide compared with the GnRH-antagonist relugolix. Coronary atherosclerosis may progress more over 12 months ...